Company

LIPAC Oncology, Inc.

Biotechnology Research 325 Sharon Park Dr 5 employees

Employees: 5
Contacts: 2
Emails: 2
Phones: 1

www.lipaconcology.com LinkedIn

LIPAC Oncology, Inc. Overview

Headquarters: 325 Sharon Park Dr
Website: www.lipaconcology.com
Industry: Biotechnology Research
Employees: 5
Founded: 2016
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About LIPAC Oncology, Inc.

LIPAC Oncology is a pharmaceutical company focused on advancing the development of new investigational therapies to treat intracavitary cancers. Its precision targeted neoliposomal technology platform provides local delivery of chemotherapy for the treatment of multiple tumor types. LiPax, its lead investigational candidate for the treatment of non-muscle invasive bladder cancer, is about to launch Phase 2b development. The Company’s pipeline includes multiple orphan indications such as upper tract urothelial carcinoma, stage II/III ovarian cancer and mesothelioma.

LIPAC Oncology, Inc. Contact Details

People in AeroLeads: 2
With contact data: 2
Email contacts: 2; 100.0% coverage
Phone contacts: 1; 50.0% coverage

LIPAC Oncology, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Karl Bean	Clinical Research Professional - Trial	Yorba Linda, California, United States	Email
Michael G. Oefelein, Md, Facs	Founder and Chief Medical Officer	Orange County, California, United States	Email Phone